Inhibitor of apoptosis protein survivin regulates vascular injury (original) (raw)
Hengartner, M.O. The biochemistry of apoptosis. Nature407, 770–776 (2000). ArticleCAS Google Scholar
Reed, J.C. Dysregulation of apoptosis in cancer. J. Clin. Oncol.17, 2941–2953 (1999). ArticleCAS Google Scholar
Walsh, K., Smith, R.C. & Kim, H.-S. Vascular cell apoptosis in remodeling, restenosis, and plaque rupture. Circ. Res.87, 184–188 (2000). ArticleCAS Google Scholar
Ross, R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature362, 801–809 (1993). ArticleCAS Google Scholar
Choy, J.C., Granville, D.J., Hunt, D.J. & McManus, B.M. Endothelial cell apoptosis: Biochemical characteristics and potential implications for atherosclerosis. J. Mol. Cell Cardiol.33, 1673–1690 (2001). ArticleCAS Google Scholar
Perlman, H., Maillard, L., Krasinski, K. & Walsh, K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation95, 981–987 (1997). ArticleCAS Google Scholar
Niemann-Jonsson, A. et al. Increased rate of apoptosis in intimal arterial smooth muscle cells through endogenous activation of TNF receptors. Arterioscler. Thromb. Vasc. Biol.21, 1909–1914 (2001). ArticleCAS Google Scholar
Schaub, F.J. et al. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nature Med.6, 790–796 (2000). ArticleCAS Google Scholar
Okura, Y. et al. Oxidized low-density lipoprotein is associated with apoptosis of vascular smooth muscle cells in human atherosclerotic plaques. Circulation102, 2680–2686 (2000). ArticleCAS Google Scholar
Bennett, M.R. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc. Res.41, 361–368 (1999). ArticleCAS Google Scholar
Miyamoto, T., Leconte, I., Swain, J.L. & Fox, J.C. Autocrine FGF signaling is required for vascular smooth muscle cell survival in vitro. J. Cell Physiol.177, 58–67 (1998). ArticleCAS Google Scholar
Obata, H. et al. NF-κB is induced in the nuclei of cultured rat aortic smooth muscle cells by stimulation of various growth factors. Biochem. Biophys. Res. Commun.224, 27–32 (1996). ArticleCAS Google Scholar
Perlman, H. et al. Adenovirus-encoded hammerhead ribozyme to Bcl-2 inhibits neointimal hyperplasia and induces vascular smooth muscle cell apoptosis. Cardiovasc. Res.45, 570–578 (2000). ArticleCAS Google Scholar
Hayakawa, Y. et al. Apoptosis and overexpression of bax protein and bax mRNA in smooth muscle cells within intimal hyperplasia of human radial arteries: Analysis with arteriovenous fistulas used for hemodialysis. Arterioscler. Thromb. Vasc. Biol.19, 2066–2077 (1999). ArticleCAS Google Scholar
Pollman, M.J., Hall, J.L., Mann, M.J., Zhang, L. & Gibbons, G.H. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nature Med.4, 222–227 (1998). ArticleCAS Google Scholar
Ekhterae, D. et al. Bcl-2 decreases voltage-gated K+ channel activity and enhances survival in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol.281, C157–165 (2001). ArticleCAS Google Scholar
Deveraux, Q.L. & Reed, J.C. IAP family proteins-suppressors of apoptosis. Genes Dev.13, 239–252 (1999). ArticleCAS Google Scholar
Altieri, D.C. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol. Med.7, 542–547 (2001). ArticleCAS Google Scholar
Hoffman, W.H., Biade, S., Zilfou, J.T., Chen, J. & Murphy, M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem.277, 3247–3257 (2001). Article Google Scholar
Tran, J. et al. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem. Biophys. Res. Commun.264, 781–788 (1999). ArticleCAS Google Scholar
O'Connor, D.S. et al. Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am. J. Pathol.156, 393–398 (2000). ArticleCAS Google Scholar
Papapetropoulos, A. et al. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J. Biol. Chem.275, 9102–9105 (2000). ArticleCAS Google Scholar
Mesri, M. et al. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am. J. Pathol.158, 1757–1765 (2001). ArticleCAS Google Scholar
Mesri, M., Wall, N.R., Li, J., Kim, R.W. & Altieri, D.C. Cancer gene therapy using a survivin mutant adenovirus. J. Clin. Invest.108, 981–990 (2001). ArticleCAS Google Scholar
O'Connor, D.S. et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc. Natl. Acad. Sci. USA97, 13103–13107 (2000). ArticleCAS Google Scholar
Grossman, D., Kim, P.J., Schechner, J.S. & Altieri, D.C. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc. Natl. Acad. Sci. USA98, 635–640 (2001). ArticleCAS Google Scholar
Li, F. et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature396, 580–584 (1998). ArticleCAS Google Scholar
Carter, B.Z., Milella, M., Altieri, D.C. & Andreeff, M. Cytokine-regulated expression of survivin in myeloid leukemia. Blood97, 2784–2790 (2001). ArticleCAS Google Scholar
Mahboubi, K. et al. Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway. Lab. Invest.81, 327–334 (2001). ArticleCAS Google Scholar
Grossman, D. et al. Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J. Clin. Invest.108, 991–999 (2001). ArticleCAS Google Scholar
Wheatley, S.P., Carvalho, A., Vagnarelli, P. & Earnshaw, W.C. INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis. Curr. Biol.11, 886–890 (2001). ArticleCAS Google Scholar
Fortugno, P. et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J. Cell Sci. (in the press).
Hart, C.E. et al. PDGFbeta receptor blockade inhibits intimal hyperplasia in the baboon. Circulation99, 564–569 (1999). ArticleCAS Google Scholar
Leppanen, O. et al. Intimal hyperplasia recurs after removal of PDGF-AB and -BB inhibition in the rat carotid artery injury model. Arterioscler. Thromb. Vasc. Biol.20, E89–95 (2000). ArticleCAS Google Scholar
Charles, R. et al. Ceramide-coated balloon catheters limit neointimal hyperplasia after stretch injury in carotid arteries. Circ. Res.87, 282–288 (2000). ArticleCAS Google Scholar
Olie, R.A. et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res.60, 2805–2809 (2000). CASPubMed Google Scholar
Pennati, M. et al. Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis. J. Clin. Invest.109, 285–286 (2002). ArticleCAS Google Scholar
Kanwar, J.R., Shen, W.P., Kanwar, R.K., Berg, R.W. & Krissansen, G.W. Effects of survivin antagonists on growth of established tumors and b7-1 immunogene therapy. J. Natl. Cancer Inst.93, 1541–1552 (2001). ArticleCAS Google Scholar
Signore, P.E. et al. Complete inhibition of intimal hyperplasia by perivascular delivery of paclitaxel in balloon-injured rat carotid arteries. J. Vasc. Interv. Radiol.12, 79–88 (2001). ArticleCAS Google Scholar
Sollott, S.J. et al. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J. Clin. Invest.95, 1869–1876 (1995). ArticleCAS Google Scholar
Fischman, D.L. et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N. Engl. J. Med.331, 496–501 (1994). ArticleCAS Google Scholar
Plescia, J., Conte, M.S., VanMeter, G., Ambrosini, G. & Altieri, D.C. Molecular identification of the cross-reacting epitope on αMβ2 integrin I domain recognized by anti-αIIbβ3 monoclonal antibody and its involvement in leukocyte adherence. J. Biol. Chem.273, 20372–20377 (1998). ArticleCAS Google Scholar